Migraine clinical trials in Connecticut
10 studies for Migraine are looking for participants at sites in Connecticut.
Cities in Connecticut
Study of EVO756 in Adults With Migraine
- Hasbani Neurology, New Haven
- New England Institute for Neurology and Headache, Stamford
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 13, 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Ki Health Partners, LLC, Stamford
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Chase Medical Research, LLC, Waterbury
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 2, 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CT Clinical Research, Cromwell
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CT Clinical Research, Cromwell
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Yale School of Medicine - The Scirex Clinical Research Unit, New Haven
- New England Institute for Clinical Research (NEICR) - Stamford, Stamford
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05164172Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- New England Institute for Clinical Research, Stamford
- Chase Medical Research, Waterbury
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2026 · NCT07646613Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- New England Institute for Clinical Research /ID# 230635, Stamford
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302Mechanistic Studies of Psilocybin in Headache Disorders
- VA Connecticut Healthcare System, West Haven
RecruitingEarly phase 1Healthy volunteers welcome
Ages 21 to 70 · All sexes · Updated Jul 13, 2026 · NCT06464367External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
RecruitingObservational study
Ages 18 to 44 · Women · Updated Apr 15, 2026 · NCT06788977From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.